EN
HI
CORONA Remedies Chart
CORONA Remedies Share Key Metrics
Volume
16267.00
Market Cap
11294.43 CR
LTQ@LTP
1@1846.70
ATP
1851.21
Var Margin
12.87 %
Circuit Range
1494.9-2242.3
Delivery %
63.57 %
Value
3.01 CR
ASM/GSM
No
Market Lot
1
Summary
CORONA Remedies share price is ₹1846.7 as of 22 Jun, 2026. The stock CORONA Remedies intraday movement has stayed between ₹1838.00 and ₹1890.20, while on a 52-week basis,CORONA Remedies price 52 week high is ₹2100.70 & its 52 week low is ₹1336.60.
In terms of trading activity, CORONA Remedies has recorded a volume of 16267 shares, The CORONA Remedies has a market cap of ₹61160088 CR. The stock’s Average Traded Price (ATP) stands at ₹1851.21, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1846.70.
CORONA Remedies operates within a circuit range of ₹1494.90 – ₹2242.30, with a Value of ₹3.01 CR. The Delivery Percentage for the day is 63.57%. Additionally, CORONA Remedies currently falls under the No framework, and trades with a market lot size of 1.
CORONA Remedies Fundamentals
P/E Ratio
61.57
P/B Ratio
15.26
Div. Yield
0.54
Sector P/E
69.22
Sector P/B
3.07
Sec. Div. Yield
0.53
CORONA Remedies Resistance and Support
Pivot 1852.93
Resistance
First Resistance
1896.56
Second Resistance
1924.53
Third Resistance
1968.16
Support
First Support
1824.96
Second Support
1781.33
Third Support
1753.36
CORONA Remedies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-11 | Audited Results & Final Dividend |
| 2026-02-02 | Quarterly Results |
| 2026-01-02 | Quarterly Results |
CORONA Remedies News
Corona Remedies Ltd - 544644 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sepia Investments, Anchor Partners, and Sage Investment Trust (collectively as PACs) sold a total of 7.49% stake in Corona Remedies through open market transactions on June 17, 2026. This significant stake reduction by substantial shareholders can be perceived negatively by the market.
Jun 19 2026 13:09:50
Corona Remedies Ltd - 544644 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sepia Investments, Anchor Partners, and Sage Investment Trust, acting in concert, sold 7.49% (45.8 lakh shares) of Corona Remedies' equity. This transaction was conducted via open market on June 17, 2026, lowering their combined stake to 13.41%.
Jun 19 2026 12:41:14
Read More
CORONA Remedies Management
| Name | Position |
|---|---|
| Kirtikumar Laxmidas Mehta | Chairman |
| Niravkumar Kirtikumar Mehta | Managing Director & Chief Executive Officer |
CORONA Remedies Similar Stocks
Concord Biotech Ltd.
1337.60
22.50 (1.71%)
Alivus Life Sciences Ltd.
1081.00
10.70 (1.00%)
Park Medi World Ltd.
289.25
11.65 (4.20%)
Marksans Pharma Ltd.
256.07
-3.60 (1.39%)
Metropolis Healthcare Ltd.
540.50
-12.25 (2.22%)
Sanofi Consumer Healthcare India Ltd.
4719.80
-92.70 (1.93%)
Viyash Scientific Ltd.
271.20
16.25 (6.37%)
Shilpa Medicare Ltd.
547.95
-3.40 (0.62%)
Strides Pharma Science Ltd.
1116.20
5.30 (0.48%)
Sudeep Pharma Ltd.
831.15
-11.80 (1.40%)
CORONA Remedies FAQs
The Buying Price of CORONA Remedies share is 1846.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy CORONA Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for CORONA Remedies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of CORONA Remedies shares is 61.57. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio CORONA Remedies shares is 15.26. Useful to assess the stock's value relative to its book value.
To assess CORONA Remedies’s valuation compare Sector P/E, P/B which are 69.22 & 3.07 with sector averages, along with growth rates and financial metrics.
The Market Cap of CORONA Remedies is 11294.43 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of CORONA Remedies share price is 2100.70 & 1336.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
CORONA Remedies belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
